Status:

RECRUITING

Feasibility, Acceptability and Preliminary Efficacy of the New Iteration of the Innovative Smartphone-based Care Solution for Women With Breast Cancer Undergoing Chemotherapy (iCareBreast+): A Pilot Study Research Proposal

Lead Sponsor:

National Cancer Centre, Singapore

Collaborating Sponsors:

Buddy Healthcare Ltd OY

Conditions:

Breast Cancer

Eligibility:

FEMALE

21-100 years

Phase:

NA

Brief Summary

The overall aim of the study is to evaluate the feasibility, acceptability and preliminary effects of the next iteration of iCareBreast+, an innovative breast care e-support intervention programme, by...

Detailed Description

A two-group pilot randomized controlled trial with pretest and post-test will be conducted in a tertiary hospital in Singapore. Women with breast cancer requiring chemotherapy (n = 40) will be recruit...

Eligibility Criteria

Inclusion

  • Women who:
  • are the age of 21 years old and above at the point of recruitment;
  • are diagnosed with stage 1-3 breast cancer;
  • will undergo chemotherapy first time (initiating or up to #4 cycles of chemo is acceptable);
  • can speak, read and write in English or Mandarin; and
  • has access to and able to use smart phone.

Exclusion

  • Those who :
  • are with a history of or concurrent other cancer types;
  • have been suffering from psychiatric illness (e.g., schizophrenia), anxiety disorder or other mood disorder or impaired cognitive function;
  • have alcohol or substance abuse within the previous year;
  • are undergoing concurrent psychosocial interventions; and
  • have been in the bereavement period in the last 6 months
  • are in their pregnancy.

Key Trial Info

Start Date :

May 23 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

October 31 2025

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT06977360

Start Date

May 23 2025

End Date

October 31 2025

Last Update

September 12 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

National Cancer Centre, Singapore

Singapore, Singapore